Erratum: Expression of concern regarding the article titled “Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in paediatric population and outcome of surgical-site infections; An open labelled, prospective, non-randomized, analytical study” (Current Research in Pharmacology and Drug Discovery (2022) 3, (S2590257122000025), (10.1016/j.crphar.2022.100082))

I am writing to formally express my concern regarding the article titled “Variability in the serum and tissue concentrations of pre-incisional ceftriaxone for surgery in the paediatric population and outcome of surgical-site infections; An open-labelled, prospective, non-randomized, analytical study” published in Current Research in Pharmacology and Drug Discovery (Sheikh et al., 2022). The primary issue pertains to the absence of a clinical trial registration number, which raises significant ethical considerations about the study's oversight and transparency. Clinical trial registration is crucial for ensuring ethical and scientific integrity in research involving human participants. This note will remain appended to the article to inform readers of these concerns until the authors provide the necessary registration details to the Editors of Current Research in Pharmacology and Drug Discovery. I appreciate the understanding and patience of all stakeholders as we seek to resolve this matter.